Clinical Trial Update: A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. [Phase 1]

View source ↗

Summary

A Phase I study evaluating inhaled sodium pyruvate for cystic fibrosis has been terminated. The trial investigated safety and tolerability in CF patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Inhaled Sodium Pyruvate (sodium pyruvate inhalation)

Snippet

Sponsor: University of Minnesota | Conditions: Cystic Fibrosis | Phase 1 | Status: TERMINATED